Effectiveness of Blood Flow Restriction Exercise Therapy to Reduce Pain in Knee Osteoarthritis Patients

NCT ID: NCT04917952

Last Updated: 2021-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-30

Study Completion Date

2021-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Resistance training of knee extensor muscles is being used in physiotherapy management in knee osteoarthritis (OA) to improve pain and physical function. Blood flow restriction (BFR) has been suggested to improve pain and increase muscle strength in healthy subjects and certain diseases. Although there are clinical studies suggesting improvements in knee osteoarthritis symptoms after 4-12 weeks of exercise with BFR, the acute effects of the intervention have not been known.

This study aims to assess the effectiveness of low load exercise therapy combined with BFR on acute pain reduction and within 24 hours post-intervention on people with knee OA compared to a placebo group.

This study will take place in Athens, Greece, as part of the postgraduate MSc program of the Physiotherapy department of the University of West Attica.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A double-blinded randomised clinical trial with a total of 42 participants will be randomly assigned to the intervention (n=21) or the control group (n=21).

The intervention group will complete a single exercise session with BFR 80%, 30% 1RM, while the control group will have sham BFR, 30% 1RM.

Pain Pressure Threshold (PPT) will be assessed with the use of a digital pressure dynamometer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BFR group

The intervention group will receive resisted knee extension 30% of 1RM with blood flow restriction.

Group Type EXPERIMENTAL

Blood Flow Restriction (BFR)

Intervention Type DEVICE

* Exercise: Bilateral knee extension at range 90ο-0ο
* Load: 30% 1RM
* BFR: Yes, 80% at both legs
* Sets: 4
* Reps: 30-15-15-15
* Rest: 30'' between sets
* Tempo: 2-0-2-0

Participants of the intervention group will receive an exercise protocol with blood flow restriction once and will be measured for changes in PPT by the use of a digital dynamometer.

Exercise protocol will be four sets of bilateral knee extension 90ο-0ο, reps per set 30-15-15-15, tempo 2-0-2-0 and rest 30 sec between sets.

In order to determine the training load 30% of 1RM, participants will perform bilateral knee extension in range 90ο-0ο with pain-free maximum resistance. The derived 1RM will be used to determine the 30% 1RM load.

Blood flow restriction will be applied at 80% by using pressure cuffs. The cuffs will be applied to the proximal thigh. Cuff pressure needed for a 100% vascular occlusion will be determined for each individual at a seated and relaxed position.

Sham BFR group

The control group will receive resisted knee extension 30% of 1RM with sham blood flow restriction.

Group Type PLACEBO_COMPARATOR

Sham Blood Flow Restriction (sham BFR)

Intervention Type DEVICE

* Exercise: Bilateral knee extension at range 90ο-0ο
* Load: 30% 1RM
* BFR: Yes, Sham BFR, 10mm Hg at both legs
* Sets: 4
* Reps: 30-15-15-15
* Rest: 30'' between sets
* Tempo: 2-0-2-0

Participants of the control group will receive an exercise protocol with sham blood flow restriction once and will be measured for changes in PPT by the use of a digital dynamometer.

Exercise protocol will be four sets of bilateral knee extension 90ο-0ο, reps per set 30-15-15-15, tempo 2-0-2-0 and rest 30 sec between sets.

In order to determine the training load 30% of 1RM, participants will perform bilateral knee extension in range 90ο-0ο with pain-free maximum resistance. The derived 1RM will be used to determine the 30% 1RM load.

Sham technique for blood flow restriction will be applied by using pressure cuffs inflated at 10mm Hg. The cuffs will be applied to the proximal thigh. Cuff pressure will be applied for each individual at a seated and relaxed position.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood Flow Restriction (BFR)

* Exercise: Bilateral knee extension at range 90ο-0ο
* Load: 30% 1RM
* BFR: Yes, 80% at both legs
* Sets: 4
* Reps: 30-15-15-15
* Rest: 30'' between sets
* Tempo: 2-0-2-0

Participants of the intervention group will receive an exercise protocol with blood flow restriction once and will be measured for changes in PPT by the use of a digital dynamometer.

Exercise protocol will be four sets of bilateral knee extension 90ο-0ο, reps per set 30-15-15-15, tempo 2-0-2-0 and rest 30 sec between sets.

In order to determine the training load 30% of 1RM, participants will perform bilateral knee extension in range 90ο-0ο with pain-free maximum resistance. The derived 1RM will be used to determine the 30% 1RM load.

Blood flow restriction will be applied at 80% by using pressure cuffs. The cuffs will be applied to the proximal thigh. Cuff pressure needed for a 100% vascular occlusion will be determined for each individual at a seated and relaxed position.

Intervention Type DEVICE

Sham Blood Flow Restriction (sham BFR)

* Exercise: Bilateral knee extension at range 90ο-0ο
* Load: 30% 1RM
* BFR: Yes, Sham BFR, 10mm Hg at both legs
* Sets: 4
* Reps: 30-15-15-15
* Rest: 30'' between sets
* Tempo: 2-0-2-0

Participants of the control group will receive an exercise protocol with sham blood flow restriction once and will be measured for changes in PPT by the use of a digital dynamometer.

Exercise protocol will be four sets of bilateral knee extension 90ο-0ο, reps per set 30-15-15-15, tempo 2-0-2-0 and rest 30 sec between sets.

In order to determine the training load 30% of 1RM, participants will perform bilateral knee extension in range 90ο-0ο with pain-free maximum resistance. The derived 1RM will be used to determine the 30% 1RM load.

Sham technique for blood flow restriction will be applied by using pressure cuffs inflated at 10mm Hg. The cuffs will be applied to the proximal thigh. Cuff pressure will be applied for each individual at a seated and relaxed position.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Kaatsu Sham Kaatsu

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current osteoarthritis clinical diagnosis according to either European League Against Rheumatism (EULAR) or American College of Rheumatology (ACR) criteria
* VAS/NRS Knee pain ≥3/10 during activity

Exclusion Criteria

* Previous experience with BFR
* Has followed knee exercise or kinesiotherapy program in the past 3 months
* New medicines in the past 3 months
* Any lower limb surgery in the past 6 months
* Knee arthroplasty surgery (Knee replacement)
* Any active healing process affecting walking (fracture, sprain, strain, etc.)
* Diagnosed with rheumatologic/neurologic disease affecting functionality
* Diagnosed or history of heart or vascular diseases
* Diagnosed with respiratory/metabolic disease
* Personal history of cancer
* Cognitive problems
* Pregnancy (only for female participants)
* Any other indication not to participate in exercise
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of West Attica

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christos Anagnostis

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

George Gioftsos

Role: STUDY_DIRECTOR

University of West Attica

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christos D. Anagnostis

Role: CONTACT

+306909921606

George Gioftsos

Role: CONTACT

+302105387485

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36676 - 27/04/202

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.